These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 35035392)

  • 1. Are we missing varices by implementing Baveno-VI recommendation of not screening patients with Compensated Advanced Chronic Liver Disease?
    Ali FS; Bader N; Zuberi BF; Rasheed T
    Pak J Med Sci; 2022; 38(1):1-8. PubMed ID: 35035392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of three "beyond Baveno VI" criteria to safely spare endoscopies in compensated advanced chronic liver disease.
    Tosetti G; Primignani M; La Mura V; D'Ambrosio R; Degasperi E; Mezzina N; Viganò M; Rumi M; Fracanzani AL; Lombardi R; Fargion S; Fraquelli M; Aghemo A; Lampertico P
    Dig Liver Dis; 2019 Aug; 51(8):1135-1140. PubMed ID: 30691777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-invasive prediction of esophageal varices by stiffness and platelet in non-alcoholic fatty liver disease cirrhosis.
    Petta S; Sebastiani G; Bugianesi E; Viganò M; Wong VW; Berzigotti A; Fracanzani AL; Anstee QM; Marra F; Barbara M; Calvaruso V; Cammà C; Di Marco V; Craxì A; de Ledinghen V
    J Hepatol; 2018 Oct; 69(4):878-885. PubMed ID: 29802949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accuracy of non-invasive methods/models for predicting esophageal varices in patients with compensated advanced chronic liver disease secondary to nonalcoholic fatty liver disease.
    Galizzi HO; Couto CA; Taranto DOL; Araújo SIO; Vilela EG
    Ann Hepatol; 2021; 20():100229. PubMed ID: 32745630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Baveno Criteria Safely Identify Patients With Compensated Advanced Chronic Liver Disease Who Can Avoid Variceal Screening Endoscopy: A Diagnostic Test Accuracy Meta-Analysis.
    Szakács Z; Erőss B; Soós A; Mátrai P; Szabó I; Pétervári E; Bajor J; Farkas N; Hegyi P; Illés A; Solymár M; Balaskó M; Sarlós P; Szűcs Á; Czimmer J; Vincze Á; Pár G
    Front Physiol; 2019; 10():1028. PubMed ID: 31481896
    [No Abstract]   [Full Text] [Related]  

  • 6. Expanding the Baveno VI criteria for the screening of varices in patients with compensated advanced chronic liver disease.
    Augustin S; Pons M; Maurice JB; Bureau C; Stefanescu H; Ney M; Blasco H; Procopet B; Tsochatzis E; Westbrook RH; Bosch J; Berzigotti A; Abraldes JG; Genescà J
    Hepatology; 2017 Dec; 66(6):1980-1988. PubMed ID: 28696510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver stiffness and serum markers for excluding high-risk varices in patients who do not meet Baveno VI criteria.
    Zhou H; Long J; Hu H; Tian CY; Lin SD
    World J Gastroenterol; 2019 Sep; 25(35):5323-5333. PubMed ID: 31558876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spleen Stiffness-Based Algorithms Are Superior to Baveno VI Criteria to Rule Out Varices Needing Treatment in Patients With Advanced Chronic Liver Disease.
    Vanderschueren E; Armandi A; Kwanten W; Cassiman D; Francque S; Schattenberg JM; Laleman W
    Am J Gastroenterol; 2024 Mar; ():. PubMed ID: 38502095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of High-Risk Varices in Patients with Compensated Advanced Chronic Liver Disease in Saudi Arabia.
    Ismail M
    Clin Exp Gastroenterol; 2023; 16():117-127. PubMed ID: 37489180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A combined model based on spleen stiffness measurement and Baveno VI criteria to rule out high-risk varices in advanced chronic liver disease.
    Colecchia A; Ravaioli F; Marasco G; Colli A; Dajti E; Di Biase AR; Bacchi Reggiani ML; Berzigotti A; Pinzani M; Festi D
    J Hepatol; 2018 Aug; 69(2):308-317. PubMed ID: 29729368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of Revised Baveno VI Criteria for Screening of Varices Needing Treatment in Children with Cirrhosis.
    Samanta T; Biswas K; Ghosh S; Gupta MK; Basu R; Purkait R; Naskar A; Butta S; Das D; Ganguly S
    Clin Exp Gastroenterol; 2020; 13():503-509. PubMed ID: 33177858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of the varices needing treatment with non-invasive tests in patients with compensated advanced chronic liver disease.
    Lee HA; Kim SU; Seo YS; Lee YS; Kang SH; Jung YK; Kim MY; Kim JH; Kim SG; Suk KT; Jung SW; Jang JY; An H; Yim HJ; Um SH
    Liver Int; 2019 Jun; 39(6):1071-1079. PubMed ID: 30589490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Baveno VI and Expanded Baveno VI criteria successfully predicts the absence of high-risk gastro-oesophageal varices in a Chilean cohort.
    Gaete MI; Díaz LA; Arenas A; González K; Cattaneo M; Fuster F; Henríquez R; Soza A; Arrese M; Barrera F; Arab JP; Benítez C
    Liver Int; 2020 Jun; 40(6):1427-1434. PubMed ID: 31916360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deciding Among Noninvasive Tools for Predicting Varices Needing Treatment in Chronic Liver Disease: An Analysis of Asian Cohort.
    Sharma S; Agarwal S; Gunjan D; Kaushal K; Anand A; Saraya A
    Am J Gastroenterol; 2020 Oct; 115(10):1650-1656. PubMed ID: 32516202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utility of different Baveno criteria to detect esophageal varices irrespective of their size in patients with compensated cirrhosis.
    Ahmed S; Sharma S; Agarwal S; Wong YJ; Putera M; Saraya A
    Indian J Gastroenterol; 2024 Jun; 43(3):609-615. PubMed ID: 37840111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of original, expanded Baveno VI, and stepwise & platelet-MELD criteria to rule out varices needing treatment in compensated cirrhosis from various etiologies.
    Nawalerspanya S; Sripongpun P; Chamroonkul N; Kongkamol C; Piratvisuth T
    Ann Hepatol; 2020; 19(2):209-213. PubMed ID: 31607647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of Esophageal Varices by Liver Stiffness and Platelets in Persons With Human Immunodeficiency Virus Infection and Compensated Advanced Chronic Liver Disease.
    Merchante N; Saroli Palumbo C; Mazzola G; Pineda JA; Téllez F; Rivero-Juárez A; Ríos-Villegas MJ; Maurice JB; Westbrook RH; Judge R; Guaraldi G; Schepis F; Perazzo H; Rockstroh J; Boesecke C; Klein MB; Cervo A; Ghali P; Wong P; Petta S; De Ledinghen V; Macías J; Sebastiani G
    Clin Infect Dis; 2020 Dec; 71(11):2810-2817. PubMed ID: 31813962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of the Expanded Baveno-VI Criteria for Screening Gastroscopy in Asian Patients with Compensated Advanced Chronic Liver Disease.
    Chang PE; Tan CK; Cheah CC; Li W; Chow WC; Wong YJ
    Dig Dis Sci; 2021 Apr; 66(4):1343-1348. PubMed ID: 32440746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Baveno VI criteria as a prognostic factor for clinical complications in patients with compensated cirrhosis.
    Asesio N; Pollo-Flores P; Caliez O; Munteanu M; Ngo A; Ngo Y; Poynard T; Thabut D; Rudler M
    Dig Liver Dis; 2022 May; 54(5):645-653. PubMed ID: 34583904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of Noninvasive Tools to Decide the Need for Beta-Blockers for Variceal Bleeding Prophylaxis in Compensated Advanced Liver Disease: A Decision Curve Analysis.
    Agarwal S; Sharma S; Jindal A; Singh S; Jagdish R; Gunjan D; Sarin SK; Saraya A
    J Clin Exp Hepatol; 2022; 12(3):917-926. PubMed ID: 35677505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.